%!TEX root = ../thesis.tex
%*******************************************************************************
%****************************** Third Chapter **********************************
%*******************************************************************************
\chapter{Conclusion}

% **************************** Define Graphics Path **************************

\graphicspath{{Chapter6/Figs/Vector/}{Chapter6/Figs/}}




There are about 20000 drugs approved for pharmaceutical use, with more being trialled every year. However, there is hesitancy in using these drugs as treatments for emerging diseases. Instead, focus is given to designer drugs which may take years to develop. It is estimated 80\% of the cost in drug design and manufacture arises simply from the developing process. This was shown to be ineffective at the time of the SARS-CoV-2 outbreak whereby the use of existing drugs was slow, and often polluted with misinformation.

In order to combat these issues, the role of active learning cannot be understated. Reviewing drugs with low manufacturing costs as treatments for incurable diseases.